SJS Investment Consulting’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7K Buy
247
+238
+2,644% +$12.2K ﹤0.01% 1022
2026
Q1
$534 Buy
9
+3
+50% +$195 ﹤0.01% 1714
2025
Q4
$371 Sell
6
-1
-14% -$61 ﹤0.01% 1624
2025
Q3
$437 Hold
7
﹤0.01% 1275
2025
Q2
$559 Sell
7
-7
-50% -$585 ﹤0.01% 1078
2025
Q1
$1.2K Buy
14
+2
+17% +$164 ﹤0.01% 942
2024
Q4
$938 Sell
12
-3
-20% -$233 ﹤0.01% 1018
2024
Q3
$1.08K Sell
15
-1
-6% -$71 ﹤0.01% 1042
2024
Q2
$1.1K Hold
16
﹤0.01% 991
2024
Q1
$1.16K Hold
16
﹤0.01% 984
2023
Q4
$980 Hold
16
﹤0.01% 966
2023
Q3
$916 Buy
16
+4
+33% +$242 ﹤0.01% 983
2023
Q2
$714 Sell
12
-5
-29% -$299 ﹤0.01% 1032
2023
Q1
$1.06K Buy
17
+3
+21% +$187 ﹤0.01% 868
2022
Q4
$876 Buy
14
+5
+56% +$287 ﹤0.01% 1001
2022
Q3
$0 Buy
+9
New +$498 ﹤0.01% 1415
2022
Q1
$0 Buy
+2
New +$115 ﹤0.01% 1179

Other funds holding PBH

SJS Investment Consulting's PBH Position: Q2 2026 in Review

SJS Investment Consulting increased its Prestige Consumer Healthcare (PBH) stake by 2,644% in Q2 2026, buying an estimated $12.2K and bringing the position to 247 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1022.

SJS Investment Consulting first reported a position in PBH in Q1 2022 and has held it in 17 quarters since. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • SJS Investment Consulting held 247 shares of Prestige Consumer Healthcare worth $11.7K as of Q2 2026.
  • SJS Investment Consulting bought 238 Prestige Consumer Healthcare shares in Q2 2026, an estimated $12.2K.
  • Prestige Consumer Healthcare made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1022 holding.
  • SJS Investment Consulting first reported a position in Prestige Consumer Healthcare in Q1 2022 and has held it in 17 quarters since.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.